ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Hard-to-Treat breast cancer in major trial
Disease control OngoingThis phase 3 trial is testing whether the targeted drug trastuzumab deruxtecan (T-DXd) works better than standard chemotherapy for people with a specific type of advanced breast cancer called HER2-low, hormone receptor positive. The study includes 866 participants whose cancer ha…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for advanced breast cancer: experimental combo targets resistant tumors
Disease control OngoingThis phase 2 trial tests a new drug called PF-07220060 combined with fulvestrant against standard treatments in 333 adults with HR-positive, HER2-negative advanced or metastatic breast cancer that has worsened after prior CDK4/6 inhibitor therapy. Half receive the experimental co…
Matched conditions: ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC